Objective: With increasing incidence of cancers globally and limited resources in some affected countries, repurposing existing drugs for reducing tumorigenesis is highly important. Artemisinin and caffeine have potent anti-oxidative and anti-tumor properties but are therapies for other diseases. This study evaluated the biochemical and p53 gene modulatory effects of doses of artemisinin-caffeine combination on breast, lungs and liver tissues in rats induced with DMBA. Methods: After due ethical approval, 30 animals were treated with 40mg/kg single dose of 7,12-dimethylbenzene anthracene (DMBA) as a model for DNA damage and induction of carcinogenesis. Five animals each received normal saline (normal), low dose artemisinin (Art; 4mg/kg), low dose caffeine (Caff; 25mg/kg), low dose combination of caff + art (25+4mg/kg), high dose combination of caff + art (50+8mg/kg) or no treatment (DMBA). All treatment doses were orally administered daily for two weeks post DMBA treatment. Nitric oxide levels and p53 relative gene expression was carried out using primer-specific RT-PCR, GAPDH was used as loading control and amplicons were resolved by gel electrophoresis. Results: DMBA induced lesions in breast, liver, and lung tissues evident from histology analysis, compared to normal group. In all 3 tissues, caffeine (25mg/kg) and combination of caff + art (25+4mg/kg) significantly reduced p53 gene expression (p < 0.05), but there was significant increase in the group treated with low dose art (4mg/kg) and high dose caff + art, which were similar to DMBA group (p<0.05). In lungs, nitric oxide (NO) increased in all groups but not in caffeine, in the liver NO decreased with caffeine or its combination with art, compared to DMBA group. Conclusions: This study shows a dose-dependent synergistic anticancer effects of caffeine and artemisinin combination on p53 gene and nitric oxide regulation hence can mitigate tumor development.
Dokunmu, T., Opara, S., Imaga, N., Awani, O., Enoma, D., & Adelani, B. (2023). P53 Gene Expression and Nitric Oxide Levels after Artemisinin-Caffeine Treatment in Breast, Lungs and Liver of DMBA-Induced Tumorigenesis. Asian Pacific Journal of Cancer Prevention, 24(2), 451-458. doi: 10.31557/APJCP.2023.24.2.451
MLA
Titilope M Dokunmu; Sandra C Opara; Ngozi Awa Imaga; Omiete U Awani; David O Enoma; Bababode I Adelani. "P53 Gene Expression and Nitric Oxide Levels after Artemisinin-Caffeine Treatment in Breast, Lungs and Liver of DMBA-Induced Tumorigenesis". Asian Pacific Journal of Cancer Prevention, 24, 2, 2023, 451-458. doi: 10.31557/APJCP.2023.24.2.451
HARVARD
Dokunmu, T., Opara, S., Imaga, N., Awani, O., Enoma, D., Adelani, B. (2023). 'P53 Gene Expression and Nitric Oxide Levels after Artemisinin-Caffeine Treatment in Breast, Lungs and Liver of DMBA-Induced Tumorigenesis', Asian Pacific Journal of Cancer Prevention, 24(2), pp. 451-458. doi: 10.31557/APJCP.2023.24.2.451
VANCOUVER
Dokunmu, T., Opara, S., Imaga, N., Awani, O., Enoma, D., Adelani, B. P53 Gene Expression and Nitric Oxide Levels after Artemisinin-Caffeine Treatment in Breast, Lungs and Liver of DMBA-Induced Tumorigenesis. Asian Pacific Journal of Cancer Prevention, 2023; 24(2): 451-458. doi: 10.31557/APJCP.2023.24.2.451
)